Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine plus irbesartan versus irbesartan alone for diabetic nephropathy with hypertension
ChiCTR-TRC-09000427Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amlodipine and irbesartan in diabetic glomerulosclerosis, hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Albumin-to-creatinine ratio change rate and Effective rate. Started Jun 2009; status: completed.
02
Drugs
amlodipineirbesartan
03
Conditions
diabetic glomerulosclerosishypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-09000427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000427.